Lou L - Search Results

1

Inhibition of STAT3-ferroptosis negative regulatory axis suppresses tumor growth and alleviates chemoresistance in gastric cancer.

Ouyang S, Li H, Lou L, Huang Q, Zhang Z, Mo J, Li M, Lu J, Zhu K, Chu Y, Ding W, Zhu J, Lin Z, Zhong L, Wang J, Yue P, Turkson J, Liu P, Wang Y, Zhang X. Ouyang S, et al. Among authors: lou l. Redox Biol. 2022 Jun;52:102317. doi: 10.1016/j.redox.2022.102317. Epub 2022 Apr 21. Redox Biol. 2022. PMID: 35483272 Free PMC article.

2

Design, Synthesis, and Evaluation of Small Molecule Gαq/11 Protein Inhibitors for the Treatment of Uveal Melanoma.

Ge Y, Shi S, Deng JJ, Chen XP, Song Z, Liu L, Lou L, Zhang X, Xiong XF. Ge Y, et al. Among authors: lou l. J Med Chem. 2021 Mar 25;64(6):3131-3152. doi: 10.1021/acs.jmedchem.0c01977. Epub 2021 Mar 15. J Med Chem. 2021. PMID: 33715360

3

Targeting mutated GTPase KRAS in tumor therapies.

Fan G, Lou L, Song Z, Zhang X, Xiong XF. Fan G, et al. Among authors: lou l. Eur J Med Chem. 2021 Dec 15;226:113816. doi: 10.1016/j.ejmech.2021.113816. Epub 2021 Sep 4. Eur J Med Chem. 2021. PMID: 34520956 Review.

4

The Double-Edged Sword of SIRT3 in Cancer and Its Therapeutic Applications.

Ouyang S, Zhang Q, Lou L, Zhu K, Li Z, Liu P, Zhang X. Ouyang S, et al. Among authors: lou l. Front Pharmacol. 2022 Apr 27;13:871560. doi: 10.3389/fphar.2022.871560. eCollection 2022. Front Pharmacol. 2022. PMID: 35571098 Free PMC article. Review.

5

Identification of novel Pyrrolo[2,3-d]Pyrimidine-based KRAS G12C inhibitors with anticancer effects.

Song Z, Lou L, Fan G, Liu L, Ge Y, Liu H, Chan ASC, Zhang X, Xiong XF. Song Z, et al. Among authors: lou l. Eur J Med Chem. 2023 Jan 5;245(Pt 1):114907. doi: 10.1016/j.ejmech.2022.114907. Epub 2022 Nov 9. Eur J Med Chem. 2023. PMID: 36395648

6

Targeting STAT3-VISTA axis to suppress tumor aggression and burden in acute myeloid leukemia.

Mo J, Deng L, Peng K, Ouyang S, Ding W, Lou L, Lin Z, Zhu J, Li J, Zhang Q, Wang P, Wen Y, Chen X, Yue P, Lu JJ, Zhu K, Zheng Y, Wang Y, Zhang X. Mo J, et al. Among authors: lou l. J Hematol Oncol. 2023 Feb 27;16(1):15. doi: 10.1186/s13045-023-01410-y. J Hematol Oncol. 2023. PMID: 36849939 Free PMC article.

7

Reprogramming of TAMs via the STAT3/CD47-SIRPα axis promotes acquired resistance to EGFR-TKIs in lung cancer.

Lu J, Li J, Lin Z, Li H, Lou L, Ding W, Ouyang S, Wu Y, Wen Y, Chen X, Yue P, Wang Y, Liu P, Lu J, Zhang J, Feng W, Zhang X. Lu J, et al. Among authors: lou l. Cancer Lett. 2023 Jun 28;564:216205. doi: 10.1016/j.canlet.2023.216205. Epub 2023 May 4. Cancer Lett. 2023. PMID: 37146936

8

Discovery of novel indazole derivatives as SOS1 agonists that activate KRAS signaling.

Liu L, Song Z, Fan G, Lou L, Wang Y, Zhang X, Xiong XF. Liu L, et al. Among authors: lou l. Bioorg Med Chem. 2023 Oct 1;93:117457. doi: 10.1016/j.bmc.2023.117457. Epub 2023 Aug 25. Bioorg Med Chem. 2023. PMID: 37688996

9

Pd(II)/Pd(IV) redox shuttle to suppress vacancy defects at grain boundaries for efficient kesterite solar cells.

Wang J, Shi J, Yin K, Meng F, Wang S, Lou L, Zhou J, Xu X, Wu H, Luo Y, Li D, Chen S, Meng Q. Wang J, et al. Among authors: lou l. Nat Commun. 2024 May 21;15(1):4344. doi: 10.1038/s41467-024-48850-9. Nat Commun. 2024. PMID: 38773145

10

Disseminated Talaromyces marneffei infection initially presenting as cutaneous and subcutaneous lesion in an HIV-Negative renal transplant recipient: a case report and literature review.

Yang S, Lou L, Ma S, Wang H, Rong L, Liu Y, Zhang K, Ai Q, Shi X. Yang S, et al. Among authors: lou l. BMC Infect Dis. 2024 May 6;24(1):473. doi: 10.1186/s12879-024-09351-8. BMC Infect Dis. 2024. PMID: 38711014 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

987 results

Search Page